Never-Event Payment Policies - How Health Plans Are Getting Tough on Preventable Hospital Errors; Implementing 'Medical Homes' to Improve Patient Care and the Bottom Line


AIS Health Plans Health Reform Pharmacy Benefit Consumer-Directed Care Compliance Market Data Health Plans
 HOME
 New on the Site
Customer Service
Sample Newsletters MarketPlace
Publications & Meetings

E-Savings Club weekly specials

Free E-Mail Newsletters
Health Business Daily
Government News
Sign Up for Free E-Mail Newsletters

Health Business Job Openings

Health Business Meetings
 
Health Plans
General Business Issues
Product News
Company Intelligence
Disease Management
Blue Cross and Blue Shield
Medicare Advantage
Managed Medicaid
People in the News
Health Plan Products
Compliance
Compliance Strategies
HIPAA Resource Center
Government Resources
Compliance Products
Pharmacy Benefit
Pharmacy Benefit Mgmt.
Specialty Pharmacy
Drug Mgmt. Products
Consumer-Directed Care
Articles on CDH
CDH Data
CDH Products
Market Data
Managed Care Enrollment
Pharmacy Benefit Mgmt.
Data Products
 
MarketPlace
Newsletters
Looseleaf Guides
Books, Directories & Reports
Live Seminars & Audioconferences
Alphabetical Listing

Health Care Links
 
Search AISHealth.com
 
Visit AISEducation.com for more news and strategic information for today's business leaders

Medicare Advantage

Future of MA Special Needs Plans After 2008 Is in Doubt

Reprinted from the May 2007 issue of MEDICARE PART D COMPLIANCE NEWS, a monthly newsletter on implementation problems and compliance strategies for the new Medicare drug benefit.

The provision in the 2003 Medicare reform law creating Special Needs Plans (SNPs) is set to expire at the end of 2008, and there is no guarantee the program will continue. That means the future of a major Part D product is in doubt.

Abby Block, director of the Center for Beneficiary Choices at CMS, told attendees at the America's Health Insurance Plan Medicare Operations Conference in Baltimore April 23 that the provision will "sunset without [congressional] legislation" extending it. If she had to venture "a guess," Block said, "at a minimum, Congress will at least extend the program, but maybe not make it permanent."

She noted that CMS is working on a required report on SNPs due to Congress in December. But it is difficult to describe the value added by the plans at this point because they are "new plans with small enrollments." "It's hard to come up with data to validate the plans," she explained.

SNPs are Medicare Advantage (MA) plans for certain classes of disadvantaged beneficiaries (e.g., Medicare-Medicaid dual eligibles, institutionalized, and the chronically ill), that must include Part D coverage. John Gorman, president and CEO of Gorman Health Plan, LLC, predicted that SNPs will benefit the most from the rapid growth of MA prescription drug plans seen in 2007.

There was a "huge increase" of almost 200 new SNPs between 2006 and 2007, he said, with CMS approving 471 SNPs for operation in 2007. Also, almost 800 Notices of Intent for SNPs have been filed for the 2008 contract year. Even if only one-quarter of these plans actually submitted applications, that will be 200 more SNPs in 2008, he explained.

One way they can keep expanding, he suggested, is that they "can keep signing up people with a special election period" throughout the year with no lock-in to worry about.

He indicated he is "now seeing" all sorts of new SNPs, such as ones for cancer patients and Alzheimer's beneficiaries. It was "intentional" on the part of CMS to leave the term 'severely chronically ill and disabled' (used to qualify Medicare beneficiaries for SNP membership) vague, Gorman suggested, "to see how the market develops."

Block, on the other hand, suggested that plan sponsors "need to demonstrate that [SNPs] have value" in order to keep them going. She strongly encouraged plans to work with states to come up with integrated products for dual-eligible beneficiaries and for plans and institutions to work together to help institutionalized beneficiaries.

CMS Tries to Differentiate SNPs

According to Block, CMS's recent 2008 MA call letter "makes sure SNPs are differentiated from other products," such as regular MA and MA private fee-for-service plans. The call letter clarifies that for 2008 dual-eligible SNPs may exclude specific groups based on the MA organization's coordination efforts with state Medicaid agencies. CMS will approve these requests on a case-by-case basis.

The agency also is planning to develop SNP quality measures to assess health outcomes (clinical, functional, and patient experiences) of enrollees in SNPs, she said.

Furthermore, Jane Andrews, director of the Division of Benefits in the Medicare Advantage Group at CMS, told attendees that there have been changes to the Plan Benefit Package (PBP) with regard to SNPs.

For 2008, plan sponsors must provide more detailed information, including the percentage, population and type of beneficiaries in the SNP, and whether the SNP consists of chronic or disabled beneficiaries if applicable, she explained.

She added that the Summary of Benefits "has been updated to reflect appropriate cost-sharing [information] depending on the type of SNP" offered by a sponsor. For example, if a SNP consists exclusively of full dual eligibles, it may offer zero cost sharing. If the SNP has different types of dual eligibles, cost sharing must consist of a range.

 

 

 

Senators Rockefeller, Hatch and Wyden, and Congressmen Stark, Waxman, Camp and Rangel to Speak at Health Reform Conference July 10-11

receive free reports

Health Plan Resources from AIS


Advertise With AIS

Privacy

Site Map


Copyright © 2008 by Atlantic Information Services, Inc. All rights reserved.
1100 17th Street, NW, Suite 300, Washington, DC 20036
Phone 202-775-9008 or 800-521-4323; E-mail
customerserv@aispub.com